Joel MENARD
机构: Professeur de Santé Publique ,faculté de médecine Paris-Descartes
每年引用次数
引用次数
引用: 36,925
H-指数: 84
I10-指数 : 375
出版物: 1,223
Assessing the French Alzheimer plan
Patrick Devos , Nicole Haeffner-Cavaillon , Sylvie Ledoux , Cécile Balandier
The Lancet 383 ( 9931) 1805
7
2014
Work environment mediates a large part of social inequalities in the incidence of several common cardiovascular risk factors: Findings from the Gazel cohort.
Pierre Meneton , Nicolas Hoertel , Emmanuel Wiernik , Cédric Lemogne
Social Science & Medicine 216 59 -66
10
2018
Clearance systems in the brain—implications for Alzheimer disease
Jenna M. Tarasoff-Conway , Roxana O. Carare , Ricardo S. Osorio , Lidia Glodzik
Nature Reviews Neurology 11 ( 8) 457 -470
1,193
2015
Erratum: Clearance systems in the brain—implications for Alzheimer diseaser
Jenna M. Tarasoff-Conway , Roxana O. Carare , Ricardo S. Osorio , Lidia Glodzik
Nature Reviews Neurology 12 ( 4) 248 -248
25
2016
Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Jürgen Bohlender , Michael Bader , Joël Ménard , Jürg Nussberger
Journal of Hypertension 30 ( 8) 1597 -1605
2
2012
Distinctive unhealthy eating pattern in free-living middle-aged hypertensives when compared with dyslipidemic or overweight patients.
Pierre Meneton , Emmanuelle Kesse-Guyot , Léopold Fezeu , Pilar Galan
Journal of Hypertension 31 ( 8) 1554 -1563
3
2013
Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.
Duncan J Campbell , Habib Karam , Patrick Bruneval , John J Mullins
Journal of Hypertension 28 ( 7) 1429 -1437
2010
Health insurance coverage is the single most prominent socioeconomic factor associated with cardiovascular drug delivery in the French population.
Pierre Meneton , Jean-Louis Lanoe , Joël Ménard
Journal of Hypertension 30 ( 3) 617 -623
8
2012
Hypertension costs: source, evolution and impact of cost-containment measures in various health-care systems
Joël Ménard
Clinical and Experimental Hypertension 11 1149 -1169
5
1989
Plasma Angiotensin in Binephrectomised Mice
Sandford Skinner , Jacob Bouhnik , Huaming Huang , Marie-Françoise Gonzalez
Clinical and Experimental Hypertension 17 ( 5) 847 -860
10
1995
Validation of the Test Your Memory (F-TYM Test) in a French memory clinic population.
Nicolas Postel-Vinay , Olivier Hanon , Pierre Clerson , Jeremy M Brown
Clinical Neuropsychologist 28 ( 6) 994 -1007
10
2014
Masked hypertension: a systematic review.
Guillaume Bobrie , Pierre Clerson , Joël Ménard , Nicolas Postel-Vinay
Journal of Hypertension 26 ( 9) 1715 -1725
209
2008
A vaccine for hypertension.
Joël Ménard
Journal of Hypertension 25 ( 1) 41 -46
14
2007
Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system.
Marc Bellet , Christian Cabrol , Paolo Sassano , Philippe Léger
American Journal of Cardiology 56 ( 15) 927 -931
124
1985
Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects: Insights From an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) Substudy
Patrick Rossignol , Joël Ménard , Renaud Fay , Finn Gustafsson
Journal of the American College of Cardiology 58 ( 19) 1958 -1966
94
2011
Evaluation of the agreement between guidelines and initial antihypertensive drug treatment using a national health care reimbursement database
Pierre Meneton , Philippe Ricordeau , Alain Weill , Philippe Tuppin
Journal of Evaluation in Clinical Practice 18 ( 3) 623 -629
9
2012
Pertinence des critères d’évaluation utilisés dans les essais cliniques sur la maladie d’Alzheimer
Philippe Truffinet , Régis Bordet , Joël Ménard
Therapie 64 ( 3) 139 -143
4
2009
Relevance of the Evaluation Criteria Used in Clinical Trials for Alzheimer’s Disease
Philippe Truffinet , Régis Bordet , Joël Ménard , Serge Bakchine
Therapie 64 ( 3) 145 -148
6
2009
The absolute risk as a guide to influence the treatment decision-making process in mild hypertension.
Gilles Chatellier , Joël Ménard
Journal of Hypertension 15 ( 3) 217 -219
16
1997
New strategies in cardiovascular disease management: Summary of round table discussion
Fritz R. Bühler , Jay N. Cohn , Kent Hermsmeyer , Joël Ménard
Journal of Hypertension 15 ( 3)
2
1997